2014/03/06 by Ludwig Kappos, Hans-Peter Hartung, Hans‐Peter Hartung +13 · 1 citation
Medicine · #Adverse effect #Clinical endpoint #Clinical trial #Double blind #Immunology #Internal medicine #Medicine #Monoclonal and Polyclonal Antibodies Research #Multiple Sclerosis Research Studies #Multiple sclerosis #Pathology #Peripheral Neuropathies and Disorders #Phases of clinical research #Placebo #Population
paper · doi:10.1016/s1474-4422(14)70028-6
openalex publication_date 2014/03/06 · crossref created 2014/03/06 · crossref issued 2014/04/01 · crossref published 2014/04/01 · crossref published-print 2014/04/01 · openalex created_date 2025/10/10 · crossref deposited 2025/10/26 · crossref indexed 2026/08/03 · openalex updated_date 2026/08/03